Overview
Feimizi Technology develops AI-assisted chemical drug R&D platforms.
Funding
Amounts as reported; USD estimates shown only when they matchListed 1 funding record. Latest funding: RMB 100M (Series B), Jun 14, 2022.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jun 14, 2022 | RMB 100M ≈ $14.3M · Series B | 挑战者创投, 正轩投资, 熊猫资本, 讯飞创投 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 1 valuation record.
No chartable valuation estimates yet.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jun 14, 2022 | — · Series B | 挑战者创投, 正轩投资, 熊猫资本, 讯飞创投 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
AI 小分子药物发现与创新药研发 费米子科技是一家化药AI辅助研发平台开发商